Shot could remove side effects from late-stage head and neck cancer therapy

by Kayla Wiles,Purdue UniversityCredit: CC0 Public DomainFor advanced stages of head and neck cancer, one of the best treatments is so aggressive that it could bring tooth decay, speech loss, co

Updated on: April 07,2024

Shot could remove side effects from late-stage head and neck cancer therapy

by Kayla Wiles,Purdue UniversityCredit: CC0 Public DomainFor advanced stages of head and neck cancer, one of the best treatments is so aggressive that it could bring tooth decay, speech loss, co

Updated on:April 07,2024

Fecal microbe transplants help cancer patients respond to immunotherapy and shrink tumors

by Diwakar Davar,The ConversationCancer patients who responded well to immunotherapy donated stool samples. Their stool was processed to yield material for a fecal microbe transplant. Credit: Di

Updated on: June 22,2024

Fecal microbe transplants help cancer patients respond to immunotherapy and shrink tumors

by Diwakar Davar,The ConversationCancer patients who responded well to immunotherapy donated stool samples. Their stool was processed to yield material for a fecal microbe transplant. Credit: Di

Updated on:June 22,2024

Cancers in distant organs alter liver function, shows study

by Jim Schnabel,Cornell UniversityRemote primary tumors induce metabolic dysfunction in the liver. Credit:Nature(2023). DOI: 10.1038/s41586-023-06114-4Cancers often release molecules

Updated on: January 22,2024

Cancers in distant organs alter liver function, shows study

by Jim Schnabel,Cornell UniversityRemote primary tumors induce metabolic dysfunction in the liver. Credit:Nature(2023). DOI: 10.1038/s41586-023-06114-4Cancers often release molecules

Updated on:January 22,2024

Blood test for brain cancer may be on horizon, research finds

byPennsylvania State UniversityCredit: Pixabay/CC0 Public DomainGlioblastoma (GBM) is the most common and deadliest type of brain cancer with a five-year survival rate of only 5%. Researchers at

Updated on: January 23,2024

Blood test for brain cancer may be on horizon, research finds

byPennsylvania State UniversityCredit: Pixabay/CC0 Public DomainGlioblastoma (GBM) is the most common and deadliest type of brain cancer with a five-year survival rate of only 5%. Researchers at

Updated on:January 23,2024

'Bone in a dish' opens new window on cancer initiation, metastasis, bone healing

by Oregon Health & Science UniversityLuiz Bertassoni D.D.S., Ph.D., and Avathamsa Athirasala, M.Sc.Eng., inspect the 3D mineral structure populated with living cells, providing a unique model

Updated on: March 13,2024

'Bone in a dish' opens new window on cancer initiation, metastasis, bone healing

by Oregon Health & Science UniversityLuiz Bertassoni D.D.S., Ph.D., and Avathamsa Athirasala, M.Sc.Eng., inspect the 3D mineral structure populated with living cells, providing a unique model

Updated on:March 13,2024

Map of tumors' immune cell populations points to new targets for immunotherapy

by Kevin Jiang,Harvard Medical SchoolMyeloid immune cells alongsidered blood cells in an electron micrograph of human blood. Credit: National Cancer InstituteThe recent emergence of immuno

Updated on: April 09,2024

Map of tumors' immune cell populations points to new targets for immunotherapy

by Kevin Jiang,Harvard Medical SchoolMyeloid immune cells alongsidered blood cells in an electron micrograph of human blood. Credit: National Cancer InstituteThe recent emergence of immuno

Updated on:April 09,2024

Microcalcification 'fingerprints' can yield info about cancer

byCornell UniversityLeft, a pathology stain of a ductal carcinoma, showing cells and connective tissue. Right, a Raman mapping of the calcification, which was captured by a technique that detect

Updated on: January 08,2024

Microcalcification 'fingerprints' can yield info about cancer

byCornell UniversityLeft, a pathology stain of a ductal carcinoma, showing cells and connective tissue. Right, a Raman mapping of the calcification, which was captured by a technique that detect

Updated on:January 08,2024

Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers

by OncotargetCONSORT diagram. Credit: Ajay SrinivasanRESILIENT was a single arm, open label, phase II/III study to test if label agnostic therapy regimens guided by Encyclopedic Tumor Analysis can off

Updated on: May 09,2024

Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers

by OncotargetCONSORT diagram. Credit: Ajay SrinivasanRESILIENT was a single arm, open label, phase II/III study to test if label agnostic therapy regimens guided by Encyclopedic Tumor Analysis can off

Updated on:May 09,2024

New therapy could help chronic myeloid leukemia patients live drug-free

by South Australian Health and Medical Research Institute (SAHMRI)Credit: AI-generated imageThe latest research from SAHMRI and the University of Adelaide has discovered a potential new therapy for ch

Updated on: January 13,2024

New therapy could help chronic myeloid leukemia patients live drug-free

by South Australian Health and Medical Research Institute (SAHMRI)Credit: AI-generated imageThe latest research from SAHMRI and the University of Adelaide has discovered a potential new therapy for ch

Updated on:January 13,2024

CAR T cell therapy may eliminate tumor cells missed by surgery

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainCAR T cell therapy, an approach which reprograms patients' own immune cells to attack their blood canc

Updated on: April 09,2024

CAR T cell therapy may eliminate tumor cells missed by surgery

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainCAR T cell therapy, an approach which reprograms patients' own immune cells to attack their blood canc

Updated on:April 09,2024

New model could reduce reliance on chemotherapy

byAnglia Ruskin UniversityCredit: Unsplash/CC0 Public DomainA model co-designed by a professor at Anglia Ruskin University is expected to reduce the need for chemotherapy in up to 38% of breast

Updated on: July 17,2024

New model could reduce reliance on chemotherapy

byAnglia Ruskin UniversityCredit: Unsplash/CC0 Public DomainA model co-designed by a professor at Anglia Ruskin University is expected to reduce the need for chemotherapy in up to 38% of breast

Updated on:July 17,2024

Front-line osimertinib improves overall survival in EGFR-mutation positive NSCLC

by European Society for Medical OncologyCredit: © European Society for Medical OncologyFirst-line osimertinib significantly lengthens overall survival compared to older generation EGFR-TKIs in pa

Updated on: May 23,2024

Front-line osimertinib improves overall survival in EGFR-mutation positive NSCLC

by European Society for Medical OncologyCredit: © European Society for Medical OncologyFirst-line osimertinib significantly lengthens overall survival compared to older generation EGFR-TKIs in pa

Updated on:May 23,2024